{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anti-tumor", "autophagy", "gracillin", "mTOR signaling pathway", "non-small cell lung cancer"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35392243", "DateRevised": {"Year": "2022", "Month": "04", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "03", "Day": "22"}], "Language": ["eng"], "ELocationID": ["851300", "10.3389/fonc.2022.851300"], "Journal": {"ISSN": "2234-943X", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in oncology", "ISOAbbreviation": "Front Oncol"}, "ArticleTitle": "Gracillin Shows Potential Efficacy Against Non-Small Cell Lung Cancer Through Inhibiting the mTOR Pathway.", "Pagination": {"StartPage": "851300", "MedlinePgn": "851300"}, "Abstract": {"AbstractText": ["The leading cause of cancer deaths is lung cancer, non-small cell lung cancer (NSCLC), the most common type of lung cancers, remains a difficult cancer to treat and cure. It is urgent to develop new products to treat NSCLS. Gracillin, extracted from <i>Reineckia carnea</i>, <i>Dioscorea villosa</i>, and other medicinal plants, has anti-tumor potential with toxic effect on a variety of tumor cells such as NSCLC. However, the anti-NSCLC mechanism of gracillin is not completely clear. In this study, A549 cells and athymic nude mice were used as models to evaluate the anti-NSCLC effects of gracillin. The antiproliferative activity of gracillin on A549 cells was conducted by CCK-8, and obvious autophagy was observed in gracillin-treated A549 through transmission electron microscopy. Furthermore, the expressions of Beclin-1, LC3-II, and WIPI1 were upregulated, while the expression of p62 was downregulated in gracillin-treated A549. The further mechanism study found that the mTOR signaling pathway was significantly inhibited by gracillin. Accordingly, the PI3K/Akt pathway positively regulating mTOR was inhibited, and AMPK negatively regulating mTOR was activated. Meanwhile, LC3-II transformation was found to be significantly reduced after WIPI1 was silenced in A549 cells but increased after gracillin treatment. It also proves that WIPI is involved in the process of gracillin regulating A549 autophagy. At last, the anti-tumor growth activity of gracillin <i>in vivo</i> was validated in A549-bearing athymic nude mice. In conclusion, gracillin has anti-NSCLC activity by inducing autophagy. The mechanism maybe that gracillin inhibited the mTOR signaling pathway. Gracillin has the potential to be a candidate product for the treatment of NSCLC in the future."], "CopyrightInformation": "Copyright \u00a9 2022 Li, Liu, Liu, Xiao, Zhang, Luo, Li and Yang."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Clinical Medicine Research Center of the First Clinical Medical College, Gannan Medical University, Ganzhou, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Gannan Medical University, Ganzhou, China."}], "LastName": "Li", "ForeName": "Yamei", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Engineering Research Center for Modernization of Traditional Chinese Medicine-Hakka Medical Resources Branch, Gannan Medical University, Ganzhou, China."}], "LastName": "Liu", "ForeName": "Hai", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Clinical Medicine Research Center of the First Clinical Medical College, Gannan Medical University, Ganzhou, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Gannan Medical University, Ganzhou, China."}], "LastName": "Liu", "ForeName": "Xiaoxuan", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Clinical Medicine Research Center of the First Clinical Medical College, Gannan Medical University, Ganzhou, China."}, {"Identifier": [], "Affiliation": "School of Rehabilitation Medicine, Gannan Medical University, Ganzhou, China."}], "LastName": "Xiao", "ForeName": "Bang", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Clinical Medicine Research Center of the First Clinical Medical College, Gannan Medical University, Ganzhou, China."}], "LastName": "Zhang", "ForeName": "Minhong", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Clinical Medicine Research Center of the First Clinical Medical College, Gannan Medical University, Ganzhou, China."}], "LastName": "Luo", "ForeName": "Yaoling", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology of the First Clinical Medical College, Gannan Medical University, Ganzhou, China."}], "LastName": "Li", "ForeName": "Mingchun", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Clinical Medicine Research Center of the First Clinical Medical College, Gannan Medical University, Ganzhou, China."}], "LastName": "Yang", "ForeName": "Jianqiong", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Oncol", "NlmUniqueID": "101568867", "ISSNLinking": "2234-943X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Torre LA, Siegel RL, Jemal A. Lung Cancer Statistics. Adv Exp Med Biol (2016) 893:1\u201319. doi:\u00a010.1007/978-3-319-24223-1_1", "ArticleIdList": ["10.1007/978-3-319-24223-1_1", "26667336"]}, {"Citation": "Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. . Estimating the Global Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods. Int J Cancer (2019) 144(8):1941\u201353. doi:\u00a010.1002/ijc.31937", "ArticleIdList": ["10.1002/ijc.31937", "30350310"]}, {"Citation": "Siegel RL, Miller KD, Jemal A. Cancer Statistic. CA Cancer J Clin (2019) 69(1):7\u201334. doi:\u00a010.3322/caac.21551", "ArticleIdList": ["10.3322/caac.21551", "30620402"]}, {"Citation": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin (2018) 68(6):394\u2013424. doi:\u00a010.3322/caac.21492", "ArticleIdList": ["10.3322/caac.21492", "30207593"]}, {"Citation": "Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global Cancer Statistic. CA Cancer J Clin (2015) 65(2):87\u2013108. doi:\u00a010.3322/caac.21262", "ArticleIdList": ["10.3322/caac.21262", "25651787"]}, {"Citation": "Chen RL, Zhao J, Zhang XC, Lou NN, Chen HJ, Yang X, et al. . Crizotinib in Advanced non-Small-Cell Lung Cancer With Concomitant ALK Rearrangement and C-Met Overexpression. BMC Cancer (2018) 18(1):1171. doi:\u00a010.1186/s12885-018-5078-y", "ArticleIdList": ["10.1186/s12885-018-5078-y", "PMC6258481", "30477470"]}, {"Citation": "Villaruz LC, Socinski MA. The Clinical Utility of PD-L1 Testing in Selecting non-Small Cell Lung Cancer Patients for PD1/PD-L1-Directed Therapy. Clin Pharmacol Ther (2016) 100(3):212\u20134. doi:\u00a010.1002/cpt.385", "ArticleIdList": ["10.1002/cpt.385", "PMC4982801", "27090296"]}, {"Citation": "Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, et al. . NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. J Natl Compr Canc Netw (2021) 19(3):254\u201366. doi:\u00a010.6004/jnccn.2021.0013", "ArticleIdList": ["10.6004/jnccn.2021.0013", "33668021"]}, {"Citation": "Garassino MC, Martelli O, Broggini M, Farina G, Veronese S, Rulli E, et al. . Erlotinib Versus Docetaxel as Second-Line Treatment of Patients With Advanced non-Small-Cell Lung Cancer and Wild-Type EGFR Tumours (TAILOR): A Randomised Controlled Trial. Lancet Oncol (2013) 14(10):981\u20138. doi:\u00a010.1016/S1470-2045(13)70310-3", "ArticleIdList": ["10.1016/S1470-2045(13)70310-3", "23883922"]}, {"Citation": "Zhou B, Tang C, Li J. K-RAS Mutation and Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment in Patients With Nonsmall Cell Lung Cancer. J Cancer Res Ther (2017) 13(4):699\u2013701. doi:\u00a010.4103/jcrt.JCRT_468_17", "ArticleIdList": ["10.4103/jcrt.JCRT_468_17", "28901317"]}, {"Citation": "Meng Z, Lv Q, Lu J, Yao H, Lv X, Jiang F, et al. . Prodrug Strategies for Paclitaxel. Int J Mol Sci (2016) 17(5):796. doi:\u00a010.3390/ijms17050796", "ArticleIdList": ["10.3390/ijms17050796", "PMC4881612", "27223283"]}, {"Citation": "Liaw K, Sharma R, Sharma A, Salazar S, Appiani La Rosa S, Kannan RM. Systemic Dendrimer Delivery of Triptolide to Tumor-Associated Macrophages Improves Anti-Tumor Efficacy and Reduces Systemic Toxicity in Glioblastoma. J Control Release (2021) 329:434\u201344. doi:\u00a010.1016/j.jconrel.2020.12.003", "ArticleIdList": ["10.1016/j.jconrel.2020.12.003", "PMC7904646", "33290796"]}, {"Citation": "Wang Q, Xu G, Jiang Y. [Analgesic and Sedative Effects of the Chinese Drug Rhizoma Paridis]. Zhongguo Zhong Yao Za Zhi (1990) 15(2):109\u2013111, 128.", "ArticleIdList": ["2390171"]}, {"Citation": "Nguyen VT, Darbour N, Bayet C, Doreau A, Raad I, Phung BH, et al. . Selective Modulation of P-Glycoprotein Activity by Steroidal Saponines From Paris Polyphylla. Fitoterapia (2009) 80(1):39\u201342. doi:\u00a010.1016/j.fitote.2008.09.010", "ArticleIdList": ["10.1016/j.fitote.2008.09.010", "18940238"]}, {"Citation": "Yang DJ, Lu TJ, Hwang LS. Isolation and Identification of Steroidal Saponins in Taiwanese Yam Cultivar (Dioscorea Pseudojaponica Yamamoto). J Agric Food Chem (2003) 51(22):6438\u201344. doi:\u00a010.1021/jf030390j", "ArticleIdList": ["10.1021/jf030390j", "14558759"]}, {"Citation": "Shim SH, Lee SY, Kim JS, Son KH, Kang SS. Norditerpenoid Alkaloids and Other Components From the Processed Tubers of Aconitum Carmichaeli. Arch Pharm Res (2005) 28(11):1239\u201343. doi:\u00a010.1007/BF02978206", "ArticleIdList": ["10.1007/BF02978206", "16350849"]}, {"Citation": "Raju J, Mehta R. Cancer Chemopreventive and Therapeutic Effects of Diosgenin, a Food Saponin. Nutr Cancer (2009) 61(1):27\u201335. doi:\u00a010.1080/01635580802357352", "ArticleIdList": ["10.1080/01635580802357352", "19116873"]}, {"Citation": "Song YX, Ou YM, Zhou JY. Gracillin Inhibits Apoptosis and Inflammation Induced by Lipopolysaccharide (LPS) to Alleviate Cardiac Injury in Mice via Improving miR-29a. Biochem Biophys Res Commun (2020) 523(3):580\u20137. doi:\u00a010.1016/j.bbrc.2019.11.129", "ArticleIdList": ["10.1016/j.bbrc.2019.11.129", "31941605"]}, {"Citation": "Liu W, Wang Y, Chen J, Lin Z, Lin M, Lin X, et al. . Beneficial Effects of Gracillin From Rhizoma Paridis Against Gastric Carcinoma via the Potential TIPE2-Mediated Induction of Endogenous Apoptosis and Inhibition of Migration in BGC823 Cells. Front Pharmacol (2021) 12:669199. doi:\u00a010.3389/fphar.2021.669199", "ArticleIdList": ["10.3389/fphar.2021.669199", "PMC8497801", "34630074"]}, {"Citation": "Zheng W, Yan CM, Zhang YB, Li ZH, Li Z, Li XY, et al. . Antiparasitic Efficacy of Gracillin and Zingibernsis Newsaponin From Costus Speciosus (Koen Ex. Retz) Sm. Against Ichthyophthirius Multifiliis. Parasitology (2015) 142(3):473\u20139. doi:\u00a010.1017/S0031182014001358", "ArticleIdList": ["10.1017/S0031182014001358", "25140457"]}, {"Citation": "Chen CR, Zhang J, Wu KW, Liu PY, Wang SJ, Chen DY, et al. . Gracillin Induces Apoptosis in HL60 Human Leukemic Cell Line via Oxidative Stress and Cell Cycle Arrest of G1. Pharmazie (2015) 70(3):199\u2013204.", "ArticleIdList": ["25980181"]}, {"Citation": "Min HY, Jang HJ, Park KH, Hyun SY, Park SJ, Kim JH, et al. . The Natural Compound Gracillin Exerts Potent Antitumor Activity by Targeting Mitochondrial Complex II. Cell Death Dis (2019) 10(11):810. doi:\u00a010.1038/s41419-019-2041-z", "ArticleIdList": ["10.1038/s41419-019-2041-z", "PMC6813327", "31649278"]}, {"Citation": "Min HY, Pei H, Hyun SY, Boo HJ, Jang HJ, Cho J, et al. . Potent Anticancer Effect of the Natural Steroidal Saponin Gracillin Is Produced by Inhibiting Glycolysis and Oxidative Phosphorylation-Mediated Bioenergetics. Cancers (Basel) (2020) 12(4):913. doi:\u00a010.3390/cancers12040913", "ArticleIdList": ["10.3390/cancers12040913", "PMC7226187", "32276500"]}, {"Citation": "Yang L, Zhu T, Ye H, Shen Y, Li Z, Chen L, et al. . Gracillin Shows Potent Efficacy Against Colorectal Cancer Through Inhibiting the STAT3 Pathway. J Cell Mol Med (2021) 25(2):801\u201312. doi:\u00a010.1111/jcmm.16134", "ArticleIdList": ["10.1111/jcmm.16134", "PMC7812262", "33259114"]}, {"Citation": "Yang J, Cao L, Li Y, Liu H, Zhang M, Ma H, et al. . Gracillin Isolated From Reineckia Carnea Induces Apoptosis of A549 Cells via the Mitochondrial Pathway. Drug Des Devel Ther (2021) 15:233\u201343. doi:\u00a010.2147/DDDT.S278975", "ArticleIdList": ["10.2147/DDDT.S278975", "PMC7829125", "33505158"]}, {"Citation": "Xu HD, Qin ZH. Beclin 1, Bcl-2 and Autophagy. Adv Exp Med Biol (2019) 1206:109\u201326. doi:\u00a010.1007/978-981-15-0602-4_5", "ArticleIdList": ["10.1007/978-981-15-0602-4_5", "31776982"]}, {"Citation": "Mizushima N. Autophagy: Process and Function. Genes Dev (2007) 21(22):2861\u201373. doi:\u00a010.1101/gad.1599207", "ArticleIdList": ["10.1101/gad.1599207", "18006683"]}, {"Citation": "Klionsky DJ. Autophagy Revisited: A Conversation With Christian De Duve. Autophagy (2008) 4(6):740\u20133. doi:\u00a010.4161/auto.6398", "ArticleIdList": ["10.4161/auto.6398", "18567941"]}, {"Citation": "Feng Y, He D, Yao Z, Klionsky DJ. The Machinery of Macroautophagy. Cell Res (2014) 24(1):24\u201341. doi:\u00a010.1038/cr.2013.168", "ArticleIdList": ["10.1038/cr.2013.168", "PMC3879710", "24366339"]}, {"Citation": "Levy JMM, Towers CG, Thorburn A. Targeting Autophagy in Cancer. Nat Rev Cancer (2017) 17(9):528\u201342. doi:\u00a010.1038/nrc.2017.53", "ArticleIdList": ["10.1038/nrc.2017.53", "PMC5975367", "28751651"]}, {"Citation": "Zhang Q, Wang X, Cao S, Sun Y, He X, Jiang B, et al. . Berberine Represses Human Gastric Cancer Cell Growth In Vitro and In Vivo by Inducing Cytostatic Autophagy via Inhibition of MAPK/mTOR/p70S6K and Akt Signaling Pathways. BioMed Pharmacother (2020) 128:110245. doi:\u00a010.1016/j.biopha.2020.110245", "ArticleIdList": ["10.1016/j.biopha.2020.110245", "32454290"]}, {"Citation": "Tsuyuki S, Takabayashi M, Kawazu M, Kudo K, Watanabe A, Nagata Y, et al. . Detection of WIPI1 mRNA as an Indicator of Autophagosome Formation. Autophagy (2014) 10(3):497\u2013513. doi:\u00a010.4161/auto.27419", "ArticleIdList": ["10.4161/auto.27419", "PMC4077887", "24384561"]}, {"Citation": "Bakula D, Muller AJ, Zuleger T, Takacs Z, Franz-Wachtel M, Thost AK, et al. . WIPI3 and WIPI4 Beta-Propellers are Scaffolds for LKB1-AMPK-TSC Signalling Circuits in the Control of Autophagy. Nat Commun (2017) 8:15637. doi:\u00a010.1038/ncomms15637", "ArticleIdList": ["10.1038/ncomms15637", "PMC5460038", "28561066"]}, {"Citation": "Tabnak P, HajiEsmailPoor Z, Soraneh S. Ferroptosis in Lung Cancer: From Molecular Mechanisms to Prognostic and Therapeutic Opportunities. Front Oncol (2021) 11:792827. doi:\u00a010.3389/fonc.2021.792827", "ArticleIdList": ["10.3389/fonc.2021.792827", "PMC8674733", "34926310"]}, {"Citation": "Chen X, Wu Q, Chen Y, Zhang J, Li H, Yang Z, et al. . Diosmetin Induces Apoptosis and Enhances the Chemotherapeutic Efficacy of Paclitaxel in non-Small Cell Lung Cancer Cells via Nrf2 Inhibition. Br J Pharmacol (2019) 176(12):2079\u201394. doi:\u00a010.1111/bph.14652", "ArticleIdList": ["10.1111/bph.14652", "PMC6534779", "30825187"]}, {"Citation": "Kocaturk NM, Akkoc Y, Kig C, Bayraktar O, Gozuacik D, Kutlu O. Autophagy as a Molecular Target for Cancer Treatment. Eur J Pharm Sci (2019) 134:116\u201337. doi:\u00a010.1016/j.ejps.2019.04.011", "ArticleIdList": ["10.1016/j.ejps.2019.04.011", "30981885"]}, {"Citation": "Russell RC, Tian Y, Yuan H, Park HW, Chang YY, Kim J, et al. . ULK1 Induces Autophagy by Phosphorylating Beclin-1 and Activating VPS34 Lipid Kinase. Nat Cell Biol (2013) 15(7):741\u201350. doi:\u00a010.1038/ncb2757", "ArticleIdList": ["10.1038/ncb2757", "PMC3885611", "23685627"]}, {"Citation": "Lamark T, Svenning S, Johansen T. Regulation of Selective Autophagy: The P62/SQSTM1 Paradigm. Essays Biochem (2017) 61(6):609\u201324. doi:\u00a010.1042/EBC20170035", "ArticleIdList": ["10.1042/EBC20170035", "29233872"]}, {"Citation": "Tanida I, Ueno T, Kominami E. LC3 and Autophagy. Methods Mol Biol (2008) 445:77\u201388. doi:\u00a010.1007/978-1-59745-157-4_4", "ArticleIdList": ["10.1007/978-1-59745-157-4_4", "18425443"]}, {"Citation": "Bakula D, Takacs Z, Proikas-Cezanne T. WIPI Beta-Propellers in Autophagy-Related Diseases and Longevity. Biochem Soc Trans (2013) 41(4):962\u20137. doi:\u00a010.1042/BST20130039", "ArticleIdList": ["10.1042/BST20130039", "23863164"]}, {"Citation": "Liao CC, Ho MY, Liang SM, Liang CM. Recombinant Protein Rvp1 Upregulates BECN1-Independent Autophagy, MAPK1/3 Phosphorylation and MMP9 Activity via WIPI1/WIPI2 to Promote Macrophage Migration. Autophagy (2013) 9(1):5\u201319. doi:\u00a010.4161/auto.22379", "ArticleIdList": ["10.4161/auto.22379", "PMC3542217", "23051912"]}, {"Citation": "De Leo MG, Berger P, Mayer A. WIPI1 Promotes Fission of Endosomal Transport Carriers and Formation of Autophagosomes Through Distinct Mechanisms. Autophagy (2021) 17(11):3644\u201370. doi:\u00a010.1080/15548627.2021.1886830", "ArticleIdList": ["10.1080/15548627.2021.1886830", "PMC8632285", "33685363"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "9"}, {"Year": "2022", "Month": "2", "Day": "28"}, {"Year": "2022", "Month": "4", "Day": "8", "Hour": "5", "Minute": "17"}, {"Year": "2022", "Month": "4", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "9", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["35392243", "PMC8980855", "10.3389/fonc.2022.851300"]}}], "PubmedBookArticle": []}